CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

FDA Clears New Treatment for Dry Eye (Cequa)

Published: Fri, 17 Aug 2018 13:07:08 EDT
Cequa is a patented, novel, proprietary nanomicellar formulation of cyclosporine A in a clear, preservative-free, aqueous solution.
FDA Approvals

FDA Expands CF Drug Kalydeco to Children as Young as Age 1 Year

Published: Fri, 17 Aug 2018 13:06:40 EDT
The drug is indicated for children as young as 12 months with at least one mutation in the CFTR gene that is responsive to the drug, as determined from clinical or in vitro assay data.
FDA Approvals

FDA Flags Temporary Artificial Heart for Mortality, Stroke Risk

Published: Fri, 17 Aug 2018 13:02:40 EDT
The letter to healthcare providers was issued after the agency reviewed final results of a postmarket study conducted by the device maker, SynCardia Systems.
News Alerts
Displaying results 4-6 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Chutes & Ladders—Gilead CMO to quit 6 months after taking the job

Published: Thu, 16 Aug 2018 16:27:27 +0000
Gilead's CMO Andrew Cheng quit six months after taking the job; Allergan tapped a Pfizer oncology veteran as CMO for some crucial pipeline help; and Novartis, reeling from the Michael Cohen scandal, recruited a Siemens veteran as its ethics chief. Those moves plus more hirings, firings and retirings throughout the industry.

Duke antidepressant startup Evecxia brings on ex-Cerecor chief as CEO

Published: Thu, 16 Aug 2018 13:59:52 +0000
Evecxia has officially named John Kaiser as its CEO and interim chairman of its board of directors. Kaiser has been working with the Duke University spinout’s management since March.

EuroBiotech Report—Pfizer-BioNTech, U.K. biotechs raise $247M and Vernalis accepts buyout bid

Published: Thu, 16 Aug 2018 13:01:43 +0000
In this week's EuroBiotech Report, Pfizer and BioNTech ink a $425 million deal, British biotechs reel in $247 million in VC cash and more.
Displaying results 4-6 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top